Cargando…
An unusual case of phenotype switch between AML FAB subtypes
Phenotypic switch between any leukemia subtypes is of concern to a treating physician and more so, in acute myelocytic leukemia (AML) as the mechanisms for switch and subsequent chemotherapy regimen to be used remain unclear. AML-non-M3 from AML-M3 subtype needs special mention as this has been unhe...
Autores principales: | Das, Animesh, Singh, Amitabh, Gajendra, Smeeta, Gupta, Ritu, Sazawal, Susha, Seth, Rachna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352367/ https://www.ncbi.nlm.nih.gov/pubmed/25767711 http://dx.doi.org/10.1002/ccr3.169 |
Ejemplares similares
-
Comment: In Response to “CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML”
por: Gajendra, Smeeta
Publicado: (2020) -
An Unusual Presentation of Hairy Cell Leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2019) -
Diffuse large B cell lymphoma with high M protein: an unusual finding
por: Dang, Manavi, et al.
Publicado: (2015) -
Mixed-phenotypic acute leukemia: cytochemically myeloid and phenotypically early T-cell precursor acute lymphoblastic leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2014) -
Dicentric (7;12)(p11;p11) in T/Myeloid Mixed-Phenotype Acute Leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2021)